back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-14 15:02 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$14,881
+29,762 vol $0.50 each |
29,762 | |
| Filed 2025-11-14 15:01 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 15:00 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$25,000
+59,524 vol $0.42 each |
59,524 | |
| Filed 2025-11-14 14:57 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 14:56 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$44,662
+89,325 vol $0.50 each |
89,325 | |
| Filed 2025-11-14 14:55 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-14 14:53 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$75,033
+178,650 vol $0.42 each |
428,650 | |
| Filed 2025-07-03 11:31 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,999
+52,083 vol $0.48 each |
73,740 | |
| Filed 2025-07-03 11:26 Tx date 2024-07-18 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,662
+21,657 vol $0.40 each |
21,657 | |
| Filed 2025-07-03 11:23 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-07-03 11:22 Tx date 2024-07-18 |
$PCRX
Proton Capital Corp. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$8,626
+21,567 vol $0.40 each |
||
| Filed 2024-07-18 13:54 Tx date 2024-07-18 |
$PCRX
Proton Capital Corp. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$8,626
+21,567 vol $0.40 each |
||
| Filed 2024-07-18 13:54 Tx date 2024-07-18 |
$PTN
Proton Capital Corp. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$8,626
+21,567 vol $0.40 each |
271,567 | |
| Filed 2024-06-11 10:22 Tx date 2024-06-06 |
$PTN
Proton Capital Corp. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2024-06-11 10:18 Tx date 2024-06-06 |
$PTN
Proton Capital Corp. |
Dumont, James
4 - Director of Issuer
Holder: JDUMONT005 (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2024-06-11 10:17 Tx date 2024-06-06 |
$PTN
Proton Capital Corp. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|